VYONDYS 53 (golodirsen) injection

VYONDYS 53 is a prescription medicine used to treat DMD. FDA approved golodirsen (brand name VYONDYS 53) is not (yet) registered or available in India but on request Indian patient can buy VYONDYS 53 at the lowest price.

VYONDYS 53-golodirsen-Price-Delhi-India
VYONDYS 53 (golodirsen) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

VYONDYS 53 (golodirsen) injection

Golodirsen, is a medication used for the treatment of Duchenne muscular dystrophy. It is an antisense oligonucleotide medication of phosphorodiamidate morpholino oligomer (PMO) chemistry.

VYONDYS 53 is used to treat patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 53.

Golodirsen, sold under the brand name Vyondys 53, is a medication used for the treatment of Duchenne muscular dystrophy. It is an antisense oligonucleotide medication of phosphorodiamidate morpholino oligomer (PMO) chemistry.

The most common side effects include headache, fever, fall, cough, vomiting, abdominal pain, cold symptoms (nasopharyngitis) and nausea.

VYONDYS 53 (golodirsen) injection, for intravenous use Initial U.S. Approval: 2019
—————-
Current Indication: Treat Duchenne muscular dystrophy (DMD).
—————-
Marketed By: Sarepta Therapeutics, Inc
—————-
Approval Date: : 2019
—————-
Active ingredient: golodirsen
—————-

Injection: 100 mg/2 mL (50 mg/mL) in a single-dose vial

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.